Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uffe Christian Braae

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Advances in Therapy|September 24, 2024
PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 DiabetesPonnusamy Saravanan, Heather Bell, Uffe Christian Braae, et al.
BMC Infectious Diseases|February 23, 2019
Stepwise approach for the control and eventual elimination of Taenia solium as a public health problemUffe Christian Braae, Sarah Gabriël, Chiara Trevisan, et al.
BMJ Open|October 29, 2025
Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in EnglandMelanie J Davies, Amra Ciric Alibegovic, Anders Boeck Jensen, et al.
Parasites & Vectors|September 22, 2018
Epidemiology of Taenia saginata taeniosis/cysticercosis: a systematic review of the distribution in the AmericasUffe Christian Braae, Lian F Thomas, Lucy J Robertson, et al.
Journal of Diabetes Investigation|July 25, 2025
A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analysesDaisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, et al.
Journal of Diabetes Investigation|August 22, 2024
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practiceDaisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, et al.
Advances in Therapy|November 23, 2022
Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study-UPDATES Saudi ArabiaMussa H AlMalki, Hossam Aldesokey, Dania Alkhafaji, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 25, 2025
PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 DiabetesRoberta Manti, Salvatore De Cosmo, Paolo Desenzani, et al.
Infection Ecology & Epidemiology|December 9, 2021
A common framework for using and reporting consumer purchase data (CPD) in foodborne outbreak investigations in EuropeSolveig Jore, Uffe Christian Braae, Frederik Trier Møller, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2024
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational StudyAnastas Kick, Khadija M'Rabet-Bensalah, Flavio Acquistapace, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Advances in Therapy|September 24, 2024
PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 DiabetesPonnusamy Saravanan, Heather Bell, Uffe Christian Braae, et al.
BMC Infectious Diseases|February 23, 2019
Stepwise approach for the control and eventual elimination of Taenia solium as a public health problemUffe Christian Braae, Sarah Gabriël, Chiara Trevisan, et al.
BMJ Open|October 29, 2025
Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in EnglandMelanie J Davies, Amra Ciric Alibegovic, Anders Boeck Jensen, et al.
Parasites & Vectors|September 22, 2018
Epidemiology of Taenia saginata taeniosis/cysticercosis: a systematic review of the distribution in the AmericasUffe Christian Braae, Lian F Thomas, Lucy J Robertson, et al.
Journal of Diabetes Investigation|July 25, 2025
A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analysesDaisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, et al.
Journal of Diabetes Investigation|August 22, 2024
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practiceDaisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, et al.
Advances in Therapy|November 23, 2022
Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study-UPDATES Saudi ArabiaMussa H AlMalki, Hossam Aldesokey, Dania Alkhafaji, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 25, 2025
PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 DiabetesRoberta Manti, Salvatore De Cosmo, Paolo Desenzani, et al.
Infection Ecology & Epidemiology|December 9, 2021
A common framework for using and reporting consumer purchase data (CPD) in foodborne outbreak investigations in EuropeSolveig Jore, Uffe Christian Braae, Frederik Trier Møller, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2024
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational StudyAnastas Kick, Khadija M'Rabet-Bensalah, Flavio Acquistapace, et al.
Pageof 4